Lansoprazole (Zoton - Lederle) is a proton pump inhibitor recently licensed for the treatment of duodenal ulcer, benign gastric ulcer or reflux oesophagitis. It is structurally related to omeprazole, which has now been available in the UK for 6 years. In this article we consider the place of lansoprazole in the treatment of patients with acid-related digestive tract disorders.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.